Upgrade to SI Premium - Free Trial

AnaptysBio (ANAB) PT Raised to $90 at UBS

March 17, 2026 6:13 AM
UBS analyst Michael Yee raised the price target on AnaptysBio (NASDAQ: ANAB) to $90.00 (from $70.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change